INTERNATIONAL PATENT: RETINAFUND FILES APPLICATION FOR "USH2A MINIPROTEIN FOR GENE THERAPY OF USHER SYNDROME TYPE II"

GENEVA, July 9 -- RETINAFUND (Shchelkovskoe shosse, dom 21, korpus 2Moscow, 105122) filed a patent application (PCT/RU2024/050227) for "USH2A MINIPROTEIN FOR GENE THERAPY OF USHER SYNDROME TYPE II" on Sep 26, 2024. With publication no. WO/2025/144082, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MALOGOLOVKIN, Aleksandr Sergeevich (ul. Novosemenkovskaya, d. 23, kv. 26Vladimirskaia oblast, Petushinskii raion, p. Volginskii, 601125), KOLESNIK, Valeriia Valerevna (ul. Stepana Razina, d. 12, kv. 4Krasnoyarsk, 660020), KATOR...